FindMyKOL
Clinical trialNCT05263076RecruitingInterventional

Uterine Transplant for Women With Absolute Uterine Factor Infertility (AUFI)

SponsorJohn GossEnrollment10Absence of UterusInfertility of Uterine OriginMayer Rokitansky Kuster Hauser Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Absolute Uterine Factor Infertility (AUFI) is due to congenital or surgical absence of a uterus or the presence of a nonfunctional uterus. Until 2014, the only option for women affected by Absolute Uterine Factor Infertility (AUFI) was adoption or surrogate motherhood. Uterine transplant is a new form of transplant to treat AUFI. The technique of uterus transplant was developed in Sweden with the transplantation of the uterus from a living donor to a woman affected by AUFI. Approximately 80 uterine transplantations have been performed, more than 50 of which have occurred within the past 3 years. To date, 34 children have been born from mothers who have received a living donor uterine transplant. This is a prospective study to treat Absolute Uterine Factor Infertility (AUFI) through uterine transplantation utilizing a uterus from a living or deceased donor resulting in live birth. A total of 10 biologically female (XX Karyotype) subjects will receive a uterine transplant.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Texas Children'S Hospital

    Houston, Texas, United States

    Caitlin Sutton, M.D.Charlotte Kim, M.D.Dean Andropoulos, M.D.James Versalovic, M.D., PhD.Jan Sunde, M.D.Jean Raphael, M.D.Jennifer Dietrich, M.D., MScJohn Goss, M.D.Julie Hakim, M.D.Kristina Reber, M.D.Larry Hollier Jr., M.D.Laura Detti, M.D.Magdalena Sanz Cortes, M.D., PhDMichael A Belfort, M.D., PhDMichael Coburn, M.D.N. Thao Galvan, M.D., MPHNicole Cirino, M.D.Ninad Patil, M.D.Peter Jindra, PhD, D(ABHI)Prakash Masand, M.D.Roshni Parikh, MDTeni Davoudian, PhDTheonia Boyd, M.D.Thierry Huisman, M.D.Xiaoming Guan, M.D., PhD.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Jun 2022
Primary completion
31 Dec 2030
Completion
31 Dec 2030
Last update posted
29 Apr 2026
Registered enrollment
10
Registry id
NCT05263076

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.